Postcontrast Acute Kidney Injury After Computed Tomography Pulmonary Angiography for Acute Pulmonary Embolism.
暂无分享,去创建一个
Min Joung Kim | J. H. Kim | Ara Cho | J. You | S. Chung | I. Park | Eun Ju Lee | Hye Jung Shin
[1] Christopher T. Chan,et al. Acute Kidney Injury in Patients Receiving Systemic Treatment for Cancer: A Population-Based Cohort Study. , 2018, Journal of the National Cancer Institute.
[2] G. Bongartz,et al. Post-contrast acute kidney injury – Part 1: Definition, clinical features, incidence, role of contrast medium and risk factors , 2018, European Radiology.
[3] J. Newhouse,et al. Intravenous Contrast-Induced Nephropathy-The Rise and Fall of a Threatening Idea. , 2017, Advances in chronic kidney disease.
[4] B. Kissela,et al. Association Between Acute Kidney Disease and Intravenous Dye Administration in Patients With Acute Stroke: A Population-Based Study , 2017, Stroke.
[5] G. Chertow,et al. Estimating the Risk of Radiocontrast-Associated Nephropathy. , 2017, Journal of the American Society of Nephrology : JASN.
[6] S. Schulman,et al. Management of venous thromboembolism: an update , 2016, Thrombosis Journal.
[7] Yunus Karaca,et al. The High Risk of Contrast-induced Nephropathy in Patients with Suspected Pulmonary Embolism Despite Three Different Prophylaxis: A Randomized Controlled Trial. , 2016, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.
[8] G. Filippatos,et al. Heart failure and kidney dysfunction: epidemiology, mechanisms and management , 2016, Nature Reviews Nephrology.
[9] A. Shirali,et al. Paraprotein-Related Kidney Disease: Evaluation and Treatment of Myeloma Cast Nephropathy. , 2016, Clinical journal of the American Society of Nephrology : CJASN.
[10] S. Yazıcı,et al. Relation of contrast nephropathy to adverse events in pulmonary emboli patients diagnosed with contrast CT. , 2016, The American journal of emergency medicine.
[11] Yun-Xia Chen,et al. Use of CRB-65 and quick Sepsis-related Organ Failure Assessment to predict site of care and mortality in pneumonia patients in the emergency department: a retrospective study , 2016, Critical Care.
[12] Guy Meyer,et al. Management of Pulmonary Embolism: An Update. , 2016, Journal of the American College of Cardiology.
[13] G. Schuler,et al. The Use of Echocardiography in Certified Chest Pain Units: Results from the German Chest Pain Unit Registry , 2016, Cardiology.
[14] J. Newhouse,et al. Controversies in Contrast Material-induced Acute Kidney Injury: Closing in on the Truth? , 2015, Radiology.
[15] D. Yealy,et al. Tintinalli's Emergency Medicine: A Comprehensive Study Guide , 2015 .
[16] Ş. Doğanay,et al. Increased risk of contrast-induced acute kidney injury in patients with pulmonary thromboembolism , 2015, Renal failure.
[17] R. Hartman,et al. Intravenous contrast material exposure is not an independent risk factor for dialysis or mortality. , 2014, Radiology.
[18] J. Ellis,et al. The challenges in assessing contrast-induced nephropathy: where are we now? , 2014, AJR. American journal of roentgenology.
[19] D. Kallmes,et al. Risk of intravenous contrast material-mediated acute kidney injury: a propensity score-matched study stratified by baseline-estimated glomerular filtration rate. , 2014, Radiology.
[20] J. Ellis,et al. Contrast material-induced nephrotoxicity and intravenous low-osmolality iodinated contrast material: risk stratification by using estimated glomerular filtration rate. , 2013, Radiology.
[21] A. Roychoudhury,et al. Quantitating contrast medium-induced nephropathy: controlling the controls. , 2013, Radiology.
[22] D. Kallmes,et al. Frequency of acute kidney injury following intravenous contrast medium administration: a systematic review and meta-analysis. , 2013, Radiology.
[23] J. Ellis,et al. Contrast material-induced nephrotoxicity and intravenous low-osmolality iodinated contrast material. , 2013, Radiology.
[24] Samuel Z Goldhaber,et al. Pulmonary embolism and deep vein thrombosis , 2012, The Lancet.
[25] G. Agnelli,et al. Acute pulmonary embolism. , 2010, The New England journal of medicine.
[26] J. Newhouse,et al. Intravenous contrast medium-induced nephrotoxicity: is the medical risk really as great as we have come to believe? , 2010, Radiology.
[27] H. Palevsky,et al. Testing low-risk patients for suspected pulmonary embolism: a decision analysis. , 2010, Annals of emergency medicine.
[28] A. Roos,et al. Incidence and predictors of contrast‐induced nephropathy following CT‐angiography for clinically suspected acute pulmonary embolism , 2010, Journal of thrombosis and haemostasis : JTH.
[29] C. Schmid,et al. A new equation to estimate glomerular filtration rate. , 2009, Annals of internal medicine.
[30] Piotr Pruszczyk,et al. Guidelines on the Diagnosis and Management of Acute Pulmonary Embolism , 2008 .
[31] T. Economopoulos,et al. Renal failure in multiple myeloma: Incidence, correlations, and prognostic significance , 2007, Leukemia & lymphoma.
[32] J. Newhouse,et al. Risk of nephropathy after intravenous administration of contrast material: a critical literature analysis. , 2006, Radiology.
[33] Lisa Moores,et al. Meta-Analysis: Outcomes in Patients with Suspected Pulmonary Embolism Managed with Computed Tomographic Pulmonary Angiography , 2004, Annals of Internal Medicine.
[34] F. Veglia,et al. Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction. , 2004, Journal of the American College of Cardiology.
[35] M. Prins,et al. Single-Detector Helical Computed Tomography as the Primary Diagnostic Test in Suspected Pulmonary Embolism: A Multicenter Clinical Management Study of 510 Patients , 2003, Annals of Internal Medicine.
[36] S. Hou,et al. Hospital-acquired renal insufficiency. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[37] J. Bida,et al. Intravenous Contrast Material-induced Nephropathy: Causal or Coincident Phenomenon? , 2016, Radiology.
[38] S. Nasr,et al. Myeloma-related kidney disease. , 2014, Advances in chronic kidney disease.
[39] R. Luciano,et al. Kidney involvement in leukemia and lymphoma. , 2014, Advances in chronic kidney disease.